Sigyn Therapeutics, Inc. (OTCMKTS:SIGY – Get Free Report) shares shot up 18.8% during trading on Wednesday . The company traded as high as $5.70 and last traded at $5.70. 200 shares changed hands during trading, an increase of 2,239% from the average session volume of 9 shares. The stock had previously closed at $4.80.
Sigyn Therapeutics Stock Performance
The firm has a 50-day simple moving average of $5.60 and a 200 day simple moving average of $5.42.
Sigyn Therapeutics (OTCMKTS:SIGY – Get Free Report) last announced its earnings results on Monday, August 19th. The company reported ($0.70) earnings per share for the quarter.
About Sigyn Therapeutics
Sigyn Therapeutics, Inc, a development-stage company, provides therapeutic solutions in the United States. Its lead product candidate is Sigyn Therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, community acquired pneumonia, drug resistant bacterial infections, and emerging pandemic threats.
Recommended Stories
- Five stocks we like better than Sigyn Therapeutics
- High Flyers: 3 Natural Gas Stocks for March 2022
- What a Trump Win Looks Like for the Market Now and Into 2025
- How to Invest in Small Cap Stocks
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Receive News & Ratings for Sigyn Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sigyn Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
